-
MEXIDOL® (Emoxipine) 125 mg, 50 coated tablets
$17.00
$22.00 -
ARPEFLU (Umifenovir) 100 mg, 20/30 caps
$24.00 – $33.00
Description
The instruction for medical use of Prostatilen® medicine (Prostatilenum®) the Trade name of Prostatilen® (Prostatilenum®) the International unlicensed name Is not present the Dosage form Suppositories rectal, 50 mg Structure One suppository contains active agent – prostates extract (Prostatilen® *) 0.05 g, excipients – a dimethyl sulfoxide, a macrogoal-1500. * – Prostatilen® substance represents prostates extract with glycine addition. The description Suppositories of a torpedo-shaped form, from white till yellow color, is allowed marbling. On a cut the marbling, existence of an air core or funneled deepening is allowed. Pharmacotherapeutic group Drugs for treatment of urological diseases. Other drugs for treatment of urological diseases. The ATX G04BX code the Pharmacological Pharmacokinetics In properties fabrics drug is split by cellular proteases to amino acids which participate in process of synthesis of tkanespetsifichesky proteins. The amino acids unused in the course of protein synthesis are deaminized and removed with urine. When using drug in the recommended mode: rektalno on 50 mg, once a day, within 10-15 days the danger of its cumulative action in an organism is excluded. The pharmacodynamics Prostatilen possesses organotropic action on a prostate. Promotes reduction of hypostasis, stagnation of a secret, leukocytic infiltration of a prostate. Normalizes secretory function of epithelial cells. Has anti-inflammatory effect. Has antiagregantny activity, interferes with development of thrombosis of venules in a prostate. Indications – chronic abacterial prostatitis – states before surgeries on a prostate – a benign hyperplasia of a prostate the Route of administration and Rektalno’s doses. On one suppository of 50 mg of 1 times a day (in the morning or in the evening). The suppository is entered deeply into an anus after defecation or a cleansing enema. Before use the suppository should be moistened with water. After introduction the stay of the patient in a bed within 30-40 minutes is desirable. A course of treatment – not less than 10 days in chronic prostatitis, not less than 15 days – in a benign hyperplasia of a prostate. Side effects – allergic reactions in case of allergic reactions stop treatment, appoint antihistamines. Contraindications – hypersensitivity to drug components – the children’s and teenage age up to 18 years Medicinal interactions Is compatible to the antibacterial drugs used for treatment of prostatitis. The special instructions Treatment of Chronic Prostatitis and States before surgeries on a prostate has to be complex, assuming use of other groups of medicines and non-drug methods of treatment. At the admission of one or several doses the treatment is not stopped, lengthening of a course of treatment on the number of the missed days of reception is recommended. To women drug is not appointed. Use of drug in chronic diseases of features has no. Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms Drug does not affect ability to run vehicles, to work with moving mechanisms and to be engaged in other potentially dangerous types of activity demanding the increased concentration of attention and speed of psychomotor reactions. Overdose Cases of overdose are not described. The form of release and packing On 5 suppositories place in blister strip packaging from a film polyvinylchloride. One or two blister strip packagings together with the instruction for medical use in the state and Russian languages are placed in a pack from cardboard. To Store storage conditions at a temperature from 2 ºС up to 15 ºС. To store out of children’s reach! 3 years not to use a period of storage after the expiration date specified on packing. Prescription status Without prescription CJSC Medicobiological Scientific-industrial Complex Tsitomed Producer, Russian Federation, 191023, St. Petersburg, Muchnoy Lane, 2, ph./fax: (812) 315-88-34, www.cytomed.ru the Name and the country of the owner of the registration certificate of CJSC Medicobiological Scientific-industrial Complex Tsitomed, the Russian Federation the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products: Pharmaline LLP, Republic of Kazakhstan, 050050, Almaty, Shamiyeva St., 11, ph.: (727) 338-48-14 (15), e-mail: info@pharmaline.kz
Reviews
There are no reviews yet.